Genetically modified mouse models have shown that complete39 or liver-specific40 inactivation of Scarb1 is associated with increased VLDL, LDL and HDL levels, and increased atherosclerosis, while over-expression of SR-BI has the opposite effect28. Here, SCARB1 is linked to atherosclerosis.